Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7)
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2510496122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Isabella Jaen Maisonet und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215. Hauptthemen laut MEDLINE: Ubiquitin-Specific Peptidase 7, Small Molecule Libraries, Enzyme Activators. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, Foundation for Hao-Fountain Syndrome.
Abstract (Originalsprache)
Ubiquitin-specific protease 7 (USP7) is a deubiquitylase essential for cell homeostasis, DNA repair, and regulation of both tumor suppressors and oncogenes. Recently, haploinsufficiency of USP7 has been associated with Hao–Fountain syndrome (HAFOUS), a rare neurodevelopmental disorder. Although a range of USP7 inhibitors have been developed over the last decade, in the context of HAFOUS, USP7 activators may represent a more relevant approach. To address this challenge, we report the identification and characterization of a small-molecule activator of USP7 called MS-8. Structural and functional studies show that MS-8 allosterically activates USP7, mimicking the endogenous autoactivation mechanism of the enzyme. We observed that MS-8 engages and activates mutant USP7 in a cellular context, impacting downstream proteins. Taken together, our study provides validation of the USP7 activator that paves the way toward activation-driven USP7 pharmacology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215.
- Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115.
- Department of Molecular Biology and Biophysics, University of Connecticut, Farmington, CT 06032.
ORCID-Profile: Isabella Jaen Maisonet, Emilie J Korchak, Anthony C Varca, Irina Bezsonova, Sara J Buhrlage
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
- Foundation for Hao-Fountain Syndrome
- Helen Gurley Brown Foundation
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- Dana-Farber Cancer Institute (DFCI)
Zitieren
APA
Jaen Maisonet, I., Sharafi, M., Korchak, E. J., Salazar-Chaparro, A., Bratt, A. S., Parikh, T., Varca, A. C., Shah, B., Darnowski, M., Chung, M., Teh, W. P., Che, J., Bezsonova, I., & Buhrlage, S. J. (2025). Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7). Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2510496122
Vancouver
Jaen Maisonet I, Sharafi M, Korchak EJ, Salazar-Chaparro A, Bratt AS, Parikh T, et al. Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7). Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2510496122
BibTeX
@article{JaenMaisonet2025,
author = {Jaen Maisonet, Isabella and Sharafi, Mona and Korchak, Emilie J and Salazar-Chaparro, Andres and Bratt, Ariana S and Parikh, Tvesha and Varca, Anthony C and Shah, Binita and Darnowski, Michael and Chung, Mia and Teh, Wei Pin and Che, Jianwei and Bezsonova, Irina and Buhrlage, Sara J},
title = {Small-molecule allosteric activator of ubiquitin-specific protease 7 (USP7)},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2510496122}
}
EUVIMED